Sfoglia per AUTORE
LEO S
Collezione ASL Torino 4

  

Items : 2

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer. in Nature medicine / Nat Med. 2023 Mar;29(3):605-614. doi: 10.1038/s41591-023-02240-8. Epub 2023 Mar 2.

2023
ASL Torino 4

Petrillo A; Gobba SM; Graham J; Longarini R; Garrone O; Zanaletti N; De Tursi M; Parisi A; Libertini M; Morelli C; Cergnul M; Depetris I; Ratti M; Fenocchio E; Zoratto F; Thomas A; Iveson T; Messina C; Pavarana M; Ross P; Rodriquenz MG; Stavraka C; Rosati G; Antonuzzo L; Mazzuca F; Merz V; Gelsomino F; Berardi R; Giampieri R; et alii...

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study. in Clinical colorectal cancer / Clin Colorectal Cancer. 2021 Dec;20(4):318-325. doi: 10.1016/j.clcc.2021.07.003. Epub 2021 Jul 18.

2021
ASL Torino 4
AOU Città della Salute di Torino

Ficorella C; D'Orazio C; Cortellini A; Petrillo A; Ierino D; Roberto M; Spinelli GP; Zoratto F; Garajova I; Ghidini M; Vitale P; Troiani T; Zanaletti N; De Galitiis F; Di Pietro FR; Tinari N; De Tursi M; Morelli C; Keränen SR; Giampieri R; Depetris I; Aimar G; Lombardi P; Claudia F; Dell'Aquila E; Spallanzani A; Leo S; Zurlo V; Gelsomino F; et alii...